These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18881491)

  • 41. Streptococcal-hyaluronidase. IV. The effect of penicillin on the production of hyaluronic acid and hyaluronidase by hemolytic streptococci (type 4, group A).
    FABER V; ROSENDAL K
    Acta Pathol Microbiol Scand; 1955; 37(3):286-92. PubMed ID: 13258239
    [No Abstract]   [Full Text] [Related]  

  • 42. Factors involved in the induction of non-specific resistance to streptococcal infection in mice by endotoxin.
    MICHAEL JG; MASSELL BF
    J Exp Med; 1962 Jul; 116(1):101-7. PubMed ID: 14473315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Interaction of group A streptococci with a culture of HEp-2 cells].
    Grabovskaia KB; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):32-6. PubMed ID: 324184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Phagocytosis of group A haemolytic streptococci by mouse macrophages. Comparison of preliminary infection of animals and degree of virulence of the strain (author's transl)].
    Wahl R; Wauquier I
    Z Immunitatsforsch Exp Klin Immunol; 1975 Feb; 148(4):273-84. PubMed ID: 126542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. THE PRESENCE OF A VIRULENCE FACTOR IN M PROTEIN EXTRACTS OF GROUP A STREPTOCOCCI. I. THE ENHANCEMENT OF VIRULENCE OF HOMOLOGOUS STREPTOCOCCI BY THESE EXTRACTS.
    KRASNER RI; YOUNG G; HEITMANN R
    J Infect Dis; 1964 Dec; 114():401-11. PubMed ID: 14233130
    [No Abstract]   [Full Text] [Related]  

  • 46. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.
    Wessels MR; Bronze MS
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12238-42. PubMed ID: 7991612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Streptococcus iniae capsule impairs phagocytic clearance and contributes to virulence in fish.
    Locke JB; Colvin KM; Datta AK; Patel SK; Naidu NN; Neely MN; Nizet V; Buchanan JT
    J Bacteriol; 2007 Feb; 189(4):1279-87. PubMed ID: 17098893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Persistence of type-specific antibodies in man following infection with group A streptococci.
    LANCEFIELD RC
    J Exp Med; 1959 Aug; 110(2):271-92. PubMed ID: 13673139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.
    Stollerman GH; Dale JB
    Clin Infect Dis; 2008 Apr; 46(7):1038-45. PubMed ID: 18444821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination equally enables both genetically susceptible and resistant mice to control infection with group A streptococci.
    Siegert J; Sastalla I; Chhatwal GS; Medina E
    Microbes Infect; 2006 Feb; 8(2):347-53. PubMed ID: 16213175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyaluronic acid capsule: strategy for oxygen resistance in group A streptococci.
    Cleary PP; Larkin A
    J Bacteriol; 1979 Dec; 140(3):1090-7. PubMed ID: 391798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New protective antigen of group A streptococci.
    Dale JB; Chiang EY; Liu S; Courtney HS; Hasty DL
    J Clin Invest; 1999 May; 103(9):1261-8. PubMed ID: 10225969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The production of capsules, hyaluronic acid and hyaluronidase by 25 strains of group C streptococci.
    MACLENNAN AP
    J Gen Microbiol; 1956 Dec; 15(3):485-91. PubMed ID: 13385432
    [No Abstract]   [Full Text] [Related]  

  • 54. THE PROPERTIES OF T ANTIGENS EXTRACTED FROM GROUP A HEMOLYTIC STREPTOCOCCI.
    Lancefield RC; Dole VP
    J Exp Med; 1946 Oct; 84(5):449-71. PubMed ID: 19871581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternate complement pathway activation by group A streptococci: role of M-protein.
    Bisno AL
    Infect Immun; 1979 Dec; 26(3):1172-6. PubMed ID: 118929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of hyaluronidase in experimental streptococcal infection.
    RUSSELL BE; SHERWOOD NP
    J Infect Dis; 1949; 84(1):81-7. PubMed ID: 18109255
    [No Abstract]   [Full Text] [Related]  

  • 57. The production of hyaluronidase by streptococci and its role in infection.
    SALLMAN B; BIRKELAND JM
    Health Cent J; 1948 Sep; 1(4):207. PubMed ID: 18887601
    [No Abstract]   [Full Text] [Related]  

  • 58. Streptococcal hyaluronidase. II. Studies on the production of hyaluronidase and hyaluronic acid by representatives of all types of hemolytic streptococci belonging to group A.
    FABER V; ROSENDAL K
    Acta Pathol Microbiol Scand; 1954; 35(2):159-64. PubMed ID: 13197034
    [No Abstract]   [Full Text] [Related]  

  • 59. Production and subsequent destruction of hyaluronic acid by certain strains of group A streptococci.
    PIKE RM
    J Infect Dis; 1948; 83(1):12-8. PubMed ID: 18869802
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of subminimal inhibitory concentrations of penicillin on hyaluronidase production by group A streptococci.
    Benchetrit LC; Avelino CC; de Oliveira CM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(2):152-6. PubMed ID: 7041483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.